First Bank & Trust’s CVS Health CVS Stock Holding History

First Bank & Trust’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-27	Closed	-$3K	–	507
2022 Q1	$3K	Hold	27	–	–	﹤0.01%	423
2021 Q4	$3K	Hold	27	–	–	﹤0.01%	418
2021 Q3	$2K	Hold	27	–	–	﹤0.01%	404
2021 Q2	$2K	Sell	27 -52	-66%	-$4.26K	﹤0.01%	393
2021 Q1	$6K	Sell	79 -54	-41%	-$3.93K	﹤0.01%	352
2020 Q4	$9K	Buy	133 +81	+156%	+$5.27K	0.01%	326
2020 Q3	$3K	Hold	52	–	–	﹤0.01%	358
2020 Q2	$3K	Hold	52	–	–	﹤0.01%	354
2020 Q1	$3K	Hold	52	–	–	﹤0.01%	355
2019 Q4	$4K	Hold	52	–	–	﹤0.01%	350
2019 Q3	$3K	Sell	52 -12	-19%	-$711	﹤0.01%	351
2019 Q2	$3K	Sell	64 -163	-72%	-$8.78K	﹤0.01%	354
2019 Q1	$12K	Sell	227 -69	-23%	-$4.26K	0.01%	241
2018 Q4	$19K	Buy	296 +121	+69%	+$9.03K	0.02%	227
2018 Q3	$13K	Hold	175	–	–	0.01%	229
2018 Q2	$11K	Hold	175	–	–	0.01%	226
2018 Q1	$11K	Sell	175 -60	-26%	-$4.3K	0.01%	227
2017 Q4	$17K	Buy	235 +6	+3%	+$436	0.01%	222
2017 Q3	$19K	Buy	+229	New	+$18.1K	0.02%	212

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

First Bank & Trust's CVS Position: Q2 2022 in Review

First Bank & Trust sold out of CVS Health (CVS) in Q2 2022, closing a stake of 27 shares — an estimated $3K sold.

First Bank & Trust first reported a position in CVS in Q3 2017 and held it in 19 quarters. The position peaked at $19K in Q4 2018. 2,307 funds tracked by Wall St. Rank hold CVS as of Q2 2022.

First Bank & Trust reported no remaining CVS Health position as of Q2 2022 after selling out during the quarter.
First Bank & Trust sold 27 CVS Health shares in Q2 2022, an estimated $3K.
First Bank & Trust first reported a position in CVS Health in Q3 2017 and held it in 19 quarters.
First Bank & Trust's CVS Health position peaked at $19K in Q4 2018.
2,307 funds tracked by Wall St. Rank held CVS Health as of Q2 2022.

Based on First Bank & Trust's 13F filing for Q2 2022, filed 22 Jul 2022.